ArticleMolecular pharmacology2015

Development of a highly selective allosteric antagonist radioligand for the type 1 cholecystokinin receptor and elucidation of its molecular basis of binding.

Maoqing Dong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.